AMOLDIPINE BENAZEPRIL HCL
- Product NDC
- 61919-852
- 11-digit product format
- 619190852
- Labeler code
- 61919
- Product ID
- 61919-852_871e47cb-a829-9ba7-e053-2991aa0a96ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- AMOLDIPINE BENAZEPRIL HCL
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA202239
- Marketing category
- ANDA
- Marketing start
- 2019-04-22
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-852-90 | 61919085290 | 90 CAPSULE in 1 BOTTLE (61919-852-90) | 90 capsule | 2019-04-22 | 0000-00-00 | No | No | Current |